MedPath

SMART Technology to Promote Heart Health in Midlife Adults

Not Applicable
Conditions
Poor Quality Sleep
Physical Activity
Hypertension
Registration Number
NCT03724474
Lead Sponsor
University of Delaware
Brief Summary

This study aims to increase weekly minutes of moderate-to-vigorous physical activity and improve sleep quality in a sample of mid-life adults between ages 50 and 64 years.

Detailed Description

This 2-year study will develop, test, and refine a cloud-based feedback system, and evaluate the impact of a 3 month randomized controlled feasibility pilot intervention - the Bio-behavioral systems to Motivate and Reinforce Heart Health trial (Be SMART) on changes in moderate-to-vigorous physical activity (MVPA) and sleep among mid-life adults between ages 50 and 64 years.

Aim 1 will examine the acceptability of the Be SMART system. We will conduct a 6-week proof- of-concept study in 10 mid-life adults to specifically examine recruitment plausibility, adherence and attrition rates, satisfaction, and implementation fidelity.

Aim 2 will quantify the impact of the Be SMART intervention (n=30) on changes in MVPA and sleep metrics compared to a Fitbit-only condition (n=30) among mid-life adults (N=60). Hypothesis 2a: At 3 months, participants in the Be SMART condition will show significantly greater weekly minutes of MVPA compared to the Fitbit-only condition, controlling for baseline. Hypothesis 2b: At 3 months, participants in the Be SMART condition will be significantly more likely to report adequate sleep duration, shorter sleep latency, and earlier sleep timing, compared to the Fitbit-only condition, controlling for baseline.

Aim 3 will explore the extent to which changes in MVPA and sleep metrics impact blood pressure changes among mid-life adults (N=60). Secondly, this study will quantify the extent to which Be SMART participants (n=30) achieve their weekly goals and if goal achievement impacts changes in blood pressure at 3 months. Hypothesis 3a: Changes in MVPA and sleep metrics will be related to changes in blood pressure. Hypothesis 3b, the degree of goal achievement will be related to changes in blood pressure.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • 50-64 years of age
  • Prehypertensive (120/80 mmHg - 139/89 mmHg) or stage 1 hypertensive (140/90 mmHg - 159/99 mmHg)
  • Physically inactive (<100 minutes of MVPA in the previous week)
  • Report insufficient sleep duration (<6 hours/night on >7 nights in the past month)
  • Own a smartphone
  • Non-smoker
  • No signs or symptoms of chronic disease
  • Have no chronic pain
  • Have no major depressive disorder, general anxiety disorder, or sleep disorder
  • Do not work alternating day-night shifts
  • Medical clearance obtained from individual's physician
Exclusion Criteria
  • Younger than 50 years; older than 64 years
  • Not prehypertensive or blood pressure is >159/99 mmHg
  • Physically active (>100 min of MVPA in the previous week)
  • Report sufficient sleep duration (>6 hours/night on 7 or more nights in the past month)
  • Does not own a smartphone
  • Current smoker
  • Report signs/symptoms of chronic disease
  • Experiences chronic pain
  • Have major depressive disorder, general anxiety disorder, or sleep disorder
  • Works alternating day and night shifts
  • Medical clearance not obtained from individual's physician

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in weekly minutes of moderate-to-vigorous physical activity over 12 weeks12 weeks

Participants will wear an accelerometer for 7 consecutive days at baseline and 12 weeks to assess physical activity intensity (e.g. light, moderate, vigorous)

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath